Our Response is Miticovin™
Miticovin™ is a promising candidate treatment that based on early results appears to slow or stop progression of Parkinson’s disease..
Medications are central to the treatment of Parkinson’s disease and can significantly improve the patient’s symptoms and overall well-being. The most commonly prescribed medications for Parkinson’s are dopaminergic agents, which work to increase dopamine levels in the brain.
Dopamine agonists, mimic the action of dopamine while other medications inhibit enzymes that break down dopamine, thus preserving its availability in the brain. Anticholinergic drugs can also be utilized to alleviate tremors and to manage dyskinesias. Individual responses to medications can vary, and careful monitoring by a healthcare professional is essential to adjust dosages and manage potential side effects.
Parkinson’s Disease
Parkinson’s disease is a progressive neurological disorder characterized by the degeneration of dopamine-producing neurons in the brain. This leads to a shortage of dopamine, a vital chemical messenger responsible for controlling movement and coordination. As a result, individuals with Parkinson’s experience a range of motor symptoms such as tremors, rigidity, and bradykinesia (slowed movements). Non-motor symptoms like depression, cognitive impairment, and sleep disturbances may also occur. While the exact cause of Parkinson’s remains unknown, its impact on both motor and non-motor functions can significantly affect a person’s daily life, making early diagnosis and comprehensive management crucial for improving quality of life.
Parkinson’s Mortality by State
CDC Updates
The Centers for Disease Control and Prevention (CDC) is a multi-departmental government organization committed to safeguarding the public’s health and wellbeing against infectious diseases.
Contact Us
Be part of the Miticovin™ solution to Parkinson’s Disease!